Published May 30, 2021 | Version v1.0.0
Review Open

Recent advances in gene therapy for atrial fibrillation

Creators

Abstract

Atrial fibrillation (AF) is the most common heart rhythm disorder in adults and a major cause of stroke. Unfortunately, current treatments for AF are suboptimal as they are not targeting the molecular mechanisms underlying AF. In this regard, gene therapy is emerging as a promising approach for mechanismbased treatment of AF. In this review, we summarize recent advances and challenges in gene therapy for this important cardiovascular disease.

Other

original_citation: Yoo S, Geist GE, Pfenniger A, Rottman M, Arora R. Recent advances in gene therapy for atrial fibrillation. J Cardiovasc Electrophysiol. 2021;32:28542864.

Files

jce.15116.pdf

Files (442.9 kB)

Name Size Download all
md5:271cb42d36d62ca37fa80f0cf784dc7d
442.9 kB Preview Download

Additional details

Identifiers

DOI
10.1111/jce.15116

Dates

Created
2021-05-30
When the item was originally created.